(Q39196167)

9 September 2017

title

Screening active anti-breast cancer compounds from Cortex Magnolia officinalis by 2D LC-MS. (English)

1 reference

9 September 2017

Magnolia officinalis

1 reference

Xiaofang Hou

1

1 reference

9 September 2017

Xilong Yuan

2

1 reference

9 September 2017

Bing Zhang

3

1 reference

9 September 2017

Sicen Wang

4

1 reference

9 September 2017

Qinhua Chen

5

1 reference

9 September 2017

publication date

1 February 2013

1 reference

Journal of Separation Science

9 September 2017

published in

1 reference

9 September 2017

volume

36

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

706-712

1 reference

9 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

5. Tanstuzumab treatment for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Overcoming drug resistance in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Natural products as sources of new drugs over the period 1981-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

The evolving role of natural products in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Lessons from natural molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Drug discovery: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Target-oriented and diversity-oriented organic synthesis in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Screening, analysis and in vitro vasodilatation of effective components from Ligusticum Chuanxiong

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Screening anti-inflammatory components from Chinese traditional medicines using a peritoneal macrophage/cell membrane chromatography-offline-GC/MS method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Comparison of alpha1-adrenergic receptor cell-membrane stationary phases prepared from expressed cell line and from rabbit hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

The preparation of HEK293 alpha1A or HEK293 alpha1B cell membrane stationary phase and the chromatographic affinity study of ligands of alpha1 adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

An online coupled cell membrane chromatography with LC/MS method for screening compounds from Aconitum carmichaeli Debx. acting on VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

A new A431/cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening epidermal growth factor receptor antagonists from Radix sophorae flavescentis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Ping wei san, a Chinese medicine for gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201200896

21 January 2018

Identifiers

DOI

10.1002/JSSC.201200896

1 reference

9 September 2017

1 reference